Reducing Disparities in Medication Adherence in SLE
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03738826|
Recruitment Status : Not yet recruiting
First Posted : November 12, 2018
Last Update Posted : November 12, 2018
|Condition or disease||Intervention/treatment||Phase|
|Systemic Lupus Erythematosus||Behavioral: Behavioral Intervention||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||50 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Reducing Disparities in Medication Adherence of Patients With Systemic Lupus Erythematosus (SLE)|
|Estimated Study Start Date :||December 2019|
|Estimated Primary Completion Date :||August 2020|
|Estimated Study Completion Date :||August 2020|
Experimental: Intervention arm
A multilevel intervention targeted towards lupus clinic providers, staff, and patients to improve medication adherence in lupus patients will be tested to assess its feasibility and acceptability.
Behavioral: Behavioral Intervention
The intervention will be developed based on quantitative and qualitative data that is currently being collected. After data collection and analysis, an intervention will be designed with input from stake holders including lupus clinic providers, staff, and patients.
- Feasibility - number of patients able to complete the intervention [ Time Frame: over 12 weeks ]Feasibility as measured by number of patients able to complete the intervention
- Acceptability - number of participants that stated the intervention was easy to use [ Time Frame: over 12 weeks ]Acceptability as measured by number of participants that stated the intervention was easy to use.
- Medication adherence [ Time Frame: over 12 weeks ]This will be determined by self report
- Medication refills [ Time Frame: over 12 weeks ]This will be determined by pharmacy refill data
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03738826
|Contact: Edna Scarlett||919 684 firstname.lastname@example.org|
|Contact: Kai Sunemail@example.com|
|Principal Investigator:||Kai Sun||Duke University|